Aligos Therapeutics (ALGS) Return on Invested Capital (2021 - 2025)
Aligos Therapeutics filings provide 5 years of Return on Invested Capital readings, the most recent being 0.0% for Q4 2025.
- On a quarterly basis, Return on Invested Capital rose 8.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 8.0% increase, with the full-year FY2025 number at 0.0%, up 2.0% from a year prior.
- Return on Invested Capital hit 0.0% in Q4 2025 for Aligos Therapeutics, up from 0.01% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2025 to a low of 0.08% in Q4 2024.
- Median Return on Invested Capital over the past 5 years was 0.01% (2025), compared with a mean of 0.01%.
- Biggest five-year swings in Return on Invested Capital: fell -7bps in 2024 and later grew 8bps in 2025.
- Aligos Therapeutics' Return on Invested Capital stood at 0.01% in 2021, then tumbled by -35bps to 0.01% in 2022, then crashed by -40bps to 0.01% in 2023, then crashed by -599bps to 0.08% in 2024, then surged by 99bps to 0.0% in 2025.
- The last three reported values for Return on Invested Capital were 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.